Back
Biodexa Pharmaceuticals PLC Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
26
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
$1.30
Seasonality Move:
-16.5%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight selling pressure.
Biodexa Pharmaceuticals PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.35 | Sell |
20-day SMA: | 1.41 | Sell |
50-day SMA: | 1.68 | Sell |
200-day SMA: | 5.77 | Sell |
8-day EMA: | 1.34 | Sell |
20-day EMA: | 1.43 | Sell |
50-day EMA: | 1.9 | Sell |
200-day EMA: | 83.86 | Sell |
Biodexa Pharmaceuticals PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 39.59 | Sell |
Chaikin Money Flow: | -12937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.34 - 1.56) | Sell |
Bollinger Bands (100): | (1.6 - 4.24) | Sell |
Biodexa Pharmaceuticals PLC Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Biodexa Pharmaceuticals PLC Stock
Is Biodexa Pharmaceuticals PLC Stock a Buy?
-
Biodexa Pharmaceuticals PLC share price is 1.31 while BDRX 8-day simple moving average is 1.35, which is a Sell signal.
-
The stock price of BDRX is 1.31 while Biodexa Pharmaceuticals PLC 20-day SMA is 1.41, which makes it a Sell.
-
Biodexa Pharmaceuticals PLC 50-day simple moving average is 1.68 while BDRX share price is 1.31, making it a Sell technically.
-
BDRX stock price is 1.31 and Biodexa Pharmaceuticals PLC 200-day simple moving average is 5.77, creating a Sell signal.
BDRX Technical Analysis vs Fundamental Analysis
Sell
26
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy or a Sell?
-
Biodexa Pharmaceuticals PLC stock is rated a SellThe current Biodexa Pharmaceuticals PLC [BDRX] share price is $1.31. The Score for BDRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Biodexa Pharmaceuticals PLC Stock Info
Market Cap:
3.4M
Price in USD:
1.31
Share Volume:
77.6K
Biodexa Pharmaceuticals PLC 52-Week Range
52-Week High:
74.00
52-Week Low:
1.11
Sell
26
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Biodexa Pharmaceuticals PLC Share Price Forecast
-
What is the Biodexa Pharmaceuticals PLC stock price today?The Biodexa Pharmaceuticals PLC stock price is 1.31 USD today.
-
Will BDRX stock go up or go down?Biodexa Pharmaceuticals PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Biodexa Pharmaceuticals PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biodexa Pharmaceuticals PLC is overvalued.
Is Biodexa Pharmaceuticals PLC Stock a Buy?
-
Biodexa Pharmaceuticals PLC share price is 1.31 while BDRX 8-day exponential moving average is 1.34, which is a Sell signal.
-
The stock price of BDRX is 1.31 while Biodexa Pharmaceuticals PLC 20-day EMA is 1.43, which makes it a Sell.
-
Biodexa Pharmaceuticals PLC 50-day exponential moving average is 1.90 while BDRX share price is 1.31, making it a Sell technically.
-
BDRX stock price is 1.31 and Biodexa Pharmaceuticals PLC 200-day simple moving average is 83.86, creating a Sell signal.
Fundamental Analysis of Biodexa Pharmaceuticals PLC
Is Biodexa Pharmaceuticals PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.04 per share.
Technical Analysis of Biodexa Pharmaceuticals PLC
Should I short Biodexa Pharmaceuticals PLC stock?
-
BDRX Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Biodexa Pharmaceuticals PLC is a Sell
-
Biodexa Pharmaceuticals PLC Relative Strength Index (RSI) is 39.59, which suggest Biodexa Pharmaceuticals PLC is oversold
-
The Bollinger Bands (25) for Biodexa Pharmaceuticals PLC is (1.34 - 1.56), which suggest Biodexa Pharmaceuticals PLC is a Sell
-
The Bollinger Bands (100) for Biodexa Pharmaceuticals PLC is (1.6 - 4.24), which suggest Biodexa Pharmaceuticals PLC is a Sell
* Biodexa Pharmaceuticals PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.